Financials
- Financial year
- 2025
- Total assets
- €8,376
- Loss
- -€5,466
- Solvency
- -29.4%
Dr. Maxime Depasse
ActiveSummary
The computed 12-month bankruptcy probability of Dr. Maxime Depasse is 3.1% (moderate). The 2025 annual accounts show negative equity (-€2,466) and a net result of -€5,466. The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
“De uitoefening van de geneeskunde door de artsen-aandeelhouder(s), meer bepaald van de geneeskunde met…” (deed in Dutch)
From the articlesNo NACE code in the KBO yet1 site
Size
€8,376total assets 2025
- Equity
- -€2,466
- Loss
- -€5,466
Turnover not published (micro format)
Why 48raises risk1 change of registered office in 24 monthsNo main activity registeredlowers riskSize: total assets €8,376Figures for financial year 2025 (filed 19-06-2026)Show the evidence
Checked score
Score 2025
48
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 15% of its sector peers (no NACE code, micro)
Financial strength
Weak
Solvency
0
equity -29.4% of total assets
Liquidity
50
short-term debt 129.4% · cash 60.9%
Profitability
0
return on assets -65.3%
Bankruptcy probability, 12 months
3.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
No credit on open account
Liquidity insufficient (current ratio 0.77, below 1; short-term debt: 129.4% and cash: 60.9% of total assets), and equity is negative.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 5% on solvency, 35% on liquidity and 4% on profitability.
The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Seven signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-06-2026, 42 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
42 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- Registered officeRegistered-office move
- IncorporationAppointment: DEPASSE Maxime Marc Gilbert…
Key points
By topic
Board & ownership
- Board
- 1 member
- DEPASSE Maxime Marc GilbertDirector
Timeline
- Events
- 3
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Founded
- 24-09-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 14
- Who signs
- Each director alone
- Annual meeting
- First Monday of June at 20:00
- Purpose
- “De uitoefening van de geneeskunde door de artsen-aandeelhouder(s), meer bepaald van de…” (deed in Dutch)
Key facts about Dr. Maxime Depasse
- What is the company number of Dr. Maxime Depasse?
- 1028.090.330. In Belgium the VAT number is the company number with BE in front: BE 1028.090.330.
- Where is Dr. Maxime Depasse based?
- The registered office is at Euterpestraat 14, 2600 Antwerpen.Company details
- What is the legal form of Dr. Maxime Depasse?
- Private limited company (BV).
- When was Dr. Maxime Depasse founded?
- On 24-09-2025.
- Is Dr. Maxime Depasse still active?
- Yes, Dr. Maxime Depasse is an active enterprise in the KBO register.
- What is the turnover of Dr. Maxime Depasse?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is Dr. Maxime Depasse profitable?
- In financial year 2025, Dr. Maxime Depasse made a loss of €5,466.
- Where can I find the annual accounts of Dr. Maxime Depasse?
- Dr. Maxime Depasse filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.